Credo Life Science
Posted on 27th January 2022

Posted on 27th January 2022

The global antidepressant and neuropathic pain market continues to grow, driving demand for high-quality active pharmaceutical ingredients. At the forefront of this demand is Duloxetine HCl — a serotonin-norepinephrine reuptake inhibitor (SNRI) used for major depressive disorder, generalised anxiety disorder, diabetic peripheral neuropathy, and fibromyalgia. Selecting the right Duloxetine HCl Manufacturer can make or break your commercial success.
Duloxetine HCl is hygroscopic, sensitive to temperature and moisture, and prone to degradation under acidic conditions. This chemical instability demands a manufacturer with precise environmental controls, specialised drying technology, and robust analytical capabilities. Furthermore, its enteric-coated pellet formulation requires mastery of polymer coating and delayed-release delivery systems.
A reliable Duloxetine HCl Manufacturer will provide comprehensive stability data under ICH Zone II, III, and IV conditions. This data is pivotal for international market registrations and demonstrates product shelf-life under diverse climatic conditions.
Credo Life Sciences has developed a robust process for manufacturing Duloxetine HCl pellets and API intermediates. Our moisture-controlled manufacturing environment, combined with our expertise in enteric coating, ensures consistent drug release profiles. We support our partners with complete regulatory dossiers, CoA documentation, and stability data packages.
When evaluating a Duloxetine HCl Manufacturer for your supply chain, prioritise regulatory compliance, technical capability, and transparency. Credo Life Sciences offers all three — delivering the quality your patients deserve.